These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells. Koga T; Az-ma T; Yuge O Acta Anaesthesiol Scand; 2002 Sep; 46(8):987-93. PubMed ID: 12190800 [TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP. Fisch A; Michael-Hepp J; Meyer J; Darius H Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography. Khanna V; Armstrong PC; Warner TD; Curzen N Platelets; 2015; 26(7):689-92. PubMed ID: 25734957 [TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation. Pallapies D; Peskar BA Thromb Res; 1993 Aug; 71(3):217-25. PubMed ID: 8211888 [TBL] [Abstract][Full Text] [Related]
7. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. Chirkov YY; Chirkova LP; Sage RE; Horowitz JD J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antiplatelet action of nitric oxide (NO) with PGD2 and its metabolite PGJ2--relevance for cerebral circulation? Rodrigues M; Fitscha P; Sinzinger H J Physiol Pharmacol; 1994 Dec; 45(4):533-9. PubMed ID: 7727795 [TBL] [Abstract][Full Text] [Related]
10. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. Bowen R; Haslam RJ J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604 [TBL] [Abstract][Full Text] [Related]
11. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Kikura M; Kazama T; Ikeda T; Sato S Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444 [TBL] [Abstract][Full Text] [Related]
12. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors. Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622 [TBL] [Abstract][Full Text] [Related]
13. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets. Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315 [TBL] [Abstract][Full Text] [Related]
14. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305 [TBL] [Abstract][Full Text] [Related]
15. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro. Weithmann KU; Just M; Schlotte V; Seiffge D Vasa; 1989; 18(4):273-6. PubMed ID: 2514520 [TBL] [Abstract][Full Text] [Related]
16. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373 [TBL] [Abstract][Full Text] [Related]
17. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Siess W; Lapetina EG Biochem J; 1990 Nov; 271(3):815-9. PubMed ID: 1700902 [TBL] [Abstract][Full Text] [Related]
18. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin. Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin. Mardla V; Kobzar G; Samel N Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103 [TBL] [Abstract][Full Text] [Related]
20. The effects of TFC-612, a 7-thia prostaglandin E1 derivative, on platelet function. Motoyama Y; Sakata Y; Seki J; Asada T; Namikawa Y; Horiai H; Ono T Thromb Res; 1991 Jul; 63(1):29-38. PubMed ID: 1658963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]